IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Midatech Pharma PLC

CUSIP: 59564R302 | 27 institutional holders

Quarters

Q2 2024Q2 2022Q1 2022Q4 2021Q3 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

Innealta Capital, LLC12
0.0% of portfolio›$11
StyleTurnoverLocationFiled
Innealta Capital, LLC
12$110.0%ETFMediumAustin, TX2024-07-29